SS
Scott Schoenhaus Keybanc Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
LifeMD
LFMD
$287M
| $6.06 | $12 |
98%
upside
| Overweight | 1 month ago |
|
|
HNGE
2
Hinge Health, Inc.
HNGE
$4.32B
| $55.07 | $60 |
9%
upside
| Overweight | 1 month ago |
|
3
Eastman Chemical
EMN
$7.93B
| $69.06 | $93 |
35%
upside
| Overweight | 1 month ago |
|
4
Doximity
DOCS
$13B
| $69.34 | $70 |
1%
upside
| Overweight | 1 month ago |
|
5
Certara
CERT
$1.69B
| $10.52 | $15 |
43%
upside
| Overweight | 1 month ago |
|
6
Albemarle
ALB
$9.6B
| $81.54 | $87 |
7%
upside
| Overweight | 1 month ago |
|
7
AbCellera Biologics
ABCL
$1.26B
| $4.22 | $10 |
137%
upside
| Overweight | 1 month ago |
|
8
Schrodinger
SDGR
$1.41B
| $19.13 | $32 |
67%
upside
| Overweight | 4 months ago |
|
9
Phreesia
PHR
$1.68B
| $28.13 | $28 |
0%
downside
| Overweight | 4 months ago |
|
10
ODDITY Tech
ODD
$3.52B
| $63 | $50 |
21%
downside
| Overweight | 4 months ago |
|
11
HealthEquity
HQY
$7.88B
| $91.48 | $100 |
9%
upside
| Overweight | 4 months ago |
|
12
Absci
ABSI
$368M
| $2.46 | $9 |
266%
upside
| Overweight | 4 months ago |
|
13
Veeva Systems
VEEV
$44.7B
| $272.93 | $255 |
7%
downside
| Overweight | 8 months ago |
|
14
Recursion Pharmaceuticals
RXRX
$2.01B
| $4.61 | $10 |
117%
upside
| Overweight | 8 months ago |
|
15
GoodRx Holdings
GDRX
$1.39B
| $4 | $6 |
50%
upside
| Overweight | 8 months ago |
|
16
Talkspace
TALK
$437M
| $2.61 | $4.50 |
72%
upside
| Overweight | 9 months ago |
|
17
Alight
ALIT
$2B
| $3.78 | $11 |
191%
upside
| Overweight | 9 months ago |
|
|
18
Alight
ALIT
$2B
| $3.78 | $15 |
297%
upside
| Overweight | 3 years ago |
|
|
19
Veeva Systems
VEEV
$44.7B
| $272.93 | $275 |
1%
upside
| Equal-Weight | 3 years ago |
|
|
20
GoodRx Holdings
GDRX
$1.39B
| $4 | $45 |
1,025%
upside
| Overweight | 3 years ago |
|
21
Teladoc Health
TDOC
$1.38B
| $7.82 | $135 |
1,626%
upside
| Equal-Weight | 3 years ago |
|
22
IQVIA
IQV
$31.9B
| $187.68 | $250 |
33%
upside
| Overweight | 4 years ago |
|